Abbvie Inc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Abbvie Inc with three other companies in this sector in the United States: Eli Lilly and Company (2018 sales of $24.56 billion of which 48% was Human pharmaceutical products - Endocrin), Abbott Laboratories ($30.58 billion of which 31% was Vascular Products), and GlaxoSmithKline plc ($41.01 billion of which 56% was Pharmaceuticals).

Sales Analysis. During the year ended December of 2018, sales at Abbvie Inc were $32.75 billion. This is an increase of 16.1% versus 2017, when the company's sales were $28.22 billion. This was the fifth consecutive year of sales increases at Abbvie Inc (and since 2013, sales have increased a total of 74%).